Yuan Yao

Yuan Yao


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Oncogene
Verified
Journal Article
Closed access
PZPingting Zhou
Pingting Zhou
YLYanyan Li
Yanyan Li
BLBo Li
Bo Li
MZMeichao Zhang
Meichao Zhang
YLYuanhua Liu
Yuanhua Liu
DLDong Li
Dong Li

1 January 2020 in International Journal of Biological Sciences
Verified
Journal Article
Open access
LBLei Bian
Lei Bian
YMYiling Meng
Yiling Meng
MZMeichao Zhang
Meichao Zhang
ZGZhuying Guo
Zhuying Guo
FLFurao Liu
Furao Liu
DLDong Li
Dong Li
Repair of damaged DNA induced by radiation plays an important role in the development of radioresistance, which greatly restricts patients' benefit from radiotherapy. However, the relation between radioresistance development and DNA double-strand break repair pathways (mainly non-homologous end joining and homologous recombination) and how these pathways contribute to radioresistance are unclear. Here, we established a radioresistant breast cancer cell line by repeated ionizing radiation and studied the alteration in DNA repair capacity. Compared with parental sham-treated cells, radioresistant breast cancer cells present elevated radioresistance, enhanced malignancy, increased expression of Ataxia-telangiectasia mutated (ATM), and increased DNA damage repair efficiency, as reflected by accelerated γ-H2AX kinetic. These defects can be reversed by ATM inhibition or ATM knockdown, indicating a potential link between ATM, DNA repair pathway and radiosensitivity. We propose that cancer cells develop elevated radioresistance through enhanced DNA damage repair efficiency mediated by increased ATM expression. Our work might provide a new evidence supporting the potential of ATM as a potential target of cancer therapy.

1 January 2019 in International Journal of Biological Sciences
Verified
Journal Article
Open access
FLFurao Liu
Furao Liu
ZXZebin Xia
Zebin Xia
MZMeichao Zhang
Meichao Zhang
JDJiping Ding
Jiping Ding
YFYang Feng
Yang Feng
DLDong Li
Dong Li
Pancreatic cancer (PC) is one of the most lethal diseases, characterized by early metastasis and high mortality. Subunits of the SWI/SNF complex have been identified in many studies as the regulators of tumor progression, but the role of SMARCAD1, one member of the SWI/SNF family, in pancreatic cancer has not been elucidated. Based on analysis of GEO database and immunohistochemical detection of patient-derived pancreatic cancer tissues, we found that SMARCAD1 is more highly expressed in pancreatic cancer tissues and that its expression level negatively correlates with patients' survival time. With further investigation, it shows that SMARCAD1 promotes the proliferation, migration, invasion of pancreatic cancer cells. Mechanistically, we first demonstrate that SMARCAD1 induces EMT via activating Wnt/β-catenin signaling pathway in pancreatic cancer. Our results provide the role and potential mechanism of SMARCAD1 in pancreatic cancer, which may prove useful marker for diagnostic or therapeutic applications of PC disease.

28 July 2023 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
MZMeichao Zhang
Meichao Zhang
YMYiling Meng
Yiling Meng
YYYingxia Ying
Yingxia Ying
PZPingting Zhou
Pingting Zhou
SZSuning Zhang
Suning Zhang
DLDong Li
Dong Li
The molecular programs that govern the directed differentiation of myeloid progenitor cells are still poorly defined. Using a previously established immortalized, phenotypically normal myeloid progenitor cell model mEB8-ER, we unveil a new mechanism mediated by STAT5 and STAT3 at a bifurcation point of myeloid progenitor cell-fate specification. We find that myeloid progenitor cells can spontaneously differentiate into neutrophils with a basal level of STAT3 phosphorylation, which is enhanced by G-CSF treatment or STAT3 over-expression, leading to elevated neutrophil differentiation. Reduced STAT3 phosphorylation caused by GM-CSF treatment, STAT3 specific inhibitor, or STAT3 depletion leads to attenuated myeloid differentiation into neutrophils, while elevating differentiation into monocytes/macrophages. In contrast, STAT5 appears to have an antagonistic function to STAT3. When activated by GM-CSF, STAT5 promotes myeloid differentiation into monocytes/macrophages but inhibits neutrophil differentiation. At the mechanistic level, GM-CSF activates STAT5 to up-regulate SOCS3, which attenuates STAT3 phosphorylation and consequently neutrophil differentiation, while enhancing monocyte/macrophage differentiation. Furthermore, inhibition of STAT5 and STAT3 in primary myeloid progenitors recapitulates the results from the mEB8-ER model. Together, our findings provide new mechanistic insights into myeloid differentiation and may prove useful for the diagnosis and treatment of diseases related to abnormal myeloid differentiation.

3 January 2019 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
WDWuheng Dong
Wuheng Dong
YYYuan Yao
Yuan Yao
XGXiaoshuang Gao
Xiaoshuang Gao
MKMiladili Keranmu
Miladili Keranmu
WLWanfang Li
Wanfang Li
ZZZhaoguo Zhang
Zhaoguo Zhang

13 August 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YLYan‐Yan Li
Yan‐Yan Li
CYChun Yang
Chun Yang
PZPingting Zhou
Pingting Zhou
SZShijie Zhang
Shijie Zhang
YYYuan Yao
Yuan Yao
DLDong Li
Dong Li